NACDS Applauds DEA Guidance on Forwarding of Electronic Prescriptions for Controlled Substances Key aspect of NACDS Regulatory Reform Initiative will benefit patients and enhance use of e-prescribing to prevent drug abuse and diversion

2017-07-21T07:42:59-04:00Categories: Press Release|Tags: , |

NACDS applauds guidance provided this week by the Drug Enforcement Administration (DEA) that addresses a priority of NACDS’ Regulatory Reform Initiative, and that simultaneously benefits patient care and the prevention of drug abuse and diversion.

NACDS Submits Comments to President’s Commission on Combating Drug Addiction and the Opioid Crisis Describes pharmacy as working partner for solutions

2017-07-10T11:57:54-04:00Categories: Press Release|Tags: , , |

NACDS President and CEO Steven C. Anderson, IOM, CAE, submitted official comments to the President’s Commission on Combating Drug Addiction and the Opioid Crisis, which reflect NACDS’ commitment to help address prescription drug abuse, addiction and proper access.

NACDS Advances “Access Agenda” Healthcare Priorities in Statements to Congress NACDS statements to Senate Finance and House Ways and Means Committees outline support for pro-patient, pro-pharmacy healthcare solutions

2017-06-14T10:16:49-04:00Categories: Press Release|Tags: , , , , , , , |

NACDS outlined support for pro-patient healthcare solutions as Congressional Committees considered the FY2018 Department of Health and Human Services budget.

Go to Top